Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Pathogenesis of asthma.

Nizar N Jarjour1, Elizabeth A B Kelly

  • 1Section of Pulmonary and Critical Care Medicine, 600 Highland Avenue, CSC K4/930, University of Wisconsin School of Medicine, Madison, WI 53792, USA. nnj@medicine.wisc.edu

The Medical Clinics of North America
|November 14, 2002
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Increased potential for atherogenic changes in asthma: evidence from transcriptomic studies of arterial endothelial cells.

Respiratory research·2026
Same author

Allergen-induced increases in adipocytokines: linking airway and systemic inflammation in asthma.

American journal of respiratory and critical care medicine·2026
Same author

Cytokines and growth factors produced and released by human eosinophils: lessons from cocultures and omics studies.

Journal of leukocyte biology·2026
Same author

PrecISE-a biomarker-stratified adaptive trial of 5 interventions in severe asthma: Final protocol and the baseline cohort.

The Journal of allergy and clinical immunology·2026
Same author

Association between absolute blood eosinophil count and carotid plaque and coronary artery calcification in the Multi-Ethnic Study of Atherosclerosis (MESA).

Journal of leukocyte biology·2026
Same author

Identification of the Cytokines, Growth Factors and Their Receptors Expressed by Human Blood Eosinophils: A Transcriptomics Approach.

Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology·2025
Same journal

Care Transitions Continue to Evolve.

The Medical clinics of North America·2026
Same journal

Navigating the Gaps: A Comprehensive Overview of Care Transitions Across the Continuum.

The Medical clinics of North America·2026
Same journal

Care Transitions and Value-Based Payment Models in the United States.

The Medical clinics of North America·2026
Same journal

Technology and Innovation in Care Transitions: Imagining the Future of Postdischarge Care.

The Medical clinics of North America·2026
Same journal

Primary Care, Specialists, and Hospitals: Bridging the Gaps in Communication and Coordination.

The Medical clinics of North America·2026
Same journal

Social Determinants of Health: Unique Considerations in Transitions of Care.

The Medical clinics of North America·2026
See all related articles

Airway inflammation is central to asthma, potentially causing injury and remodeling. Early anti-inflammatory therapy, like inhaled steroids, may modify disease progression and improve asthma control.

Area of Science:

  • Pulmonology
  • Immunology
  • Pharmacology

Background:

  • Airway inflammation is a primary issue in asthma, potentially leading to airway injury and remodeling.
  • Longstanding asthma may cause loss of elastic recoil, worsening airway obstruction and control.
  • Current therapies effectively manage asthma for most but not all patients.

Purpose of the Study:

  • To review the role of anti-inflammatory therapy in asthma management.
  • To highlight the potential of early intervention to limit disease progression.
  • To discuss future directions in personalized asthma treatment.

Main Methods:

  • Review of existing literature and clinical guidelines.
  • Analysis of evidence for inhaled corticosteroids as first-line therapy.

Related Experiment Videos

  • Discussion of the role of genetics and pharmacogenetics in asthma.
  • Main Results:

    • Inhaled steroids are recommended as first-line therapy for persistent asthma.
    • Early anti-inflammatory treatment may modify disease and limit airway remodeling.
    • A subset of patients still develops severe, refractory asthma.

    Conclusions:

    • Anti-inflammatory therapy is crucial for asthma management.
    • Personalized treatment based on genetics and pharmacogenetics is the future of asthma care.
    • Improved understanding of asthma pathogenesis will enhance patient outcomes and reduce medication side effects.